Related Experiment Video
Updated: Aug 22, 2026

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
Adipose-specific Kdm2a deficiency promotes ferroptosis-associated features and hypertrophic remodeling of adipocytes
An Li1, Binglin Yue2, Hanzhuo Hu3
1Key Laboratory of Qinghai-Tibetan Plateau Animal Genetic Resource Reservation and Utilization, Ministry of Education, Southwest Minzu University, Chengdu, China; College of Animal & Veterinary Sciences, Southwest Minzu University, Chengdu, China; Academy of Agricultural Sciences. Liang Shan, Xichang, China.
Abstract:
Appropriate adipose tissue deposition plays a critical role in regulating systemic energy metabolic homeostasis. Epigenetic mechanisms have emerged as critical modulators of these processes; however, the role of specific histone demethylases in adipocytes remains poorly understood. Here, we investigated the physiological function of lysine demethylase 2A (Kdm2a) in adipose tissue using adipocyte-specific Kdm2a knockout (Kdm2aFatKO) mice under normal and high-fat dietary conditions. Although Kdm2a deficiency reduced overall fat mass and partially protected against diet-induced weight gain, it paradoxically induced pronounced adipocyte hypertrophy, insulin resistance, impaired energy metabolism, and adipose tissue dysfunction. Integrated transcriptomic and functional analyses revealed that loss of Kdm2a is accompanied by ferroptosis-associated features in adipocytes, an iron-dependent form of regulated cell death driven by lipid peroxidation. Ferroptosis activation was linked to epigenetic dysregulation to oxidative damage and metabolic collapse. Collectively, our findings identify Kdm2a as a critical epigenetic guardian of adipocyte integrity and establish a previously unrecognized connection between adipocyte hypertrophic remodeling and ferroptosis-associated features in metabolic disease.
Related Concept Videos
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
